Dr. Sara Tegami

Responsible for introducing and driving the market adoption of New Technologies in the assigned territory, with a specific near-term focus on the FDS franchise. New Technologies champion, closely partnering with the in-country sales/marketing organization to develop and execute targeted sales and marketing programs to achieve near-term revenue targets and fuel future growth.

• conception/assembling/conduction of experiments in different international research groups • development and test of new measurement methods in radiotherapy • international presentation and publication of results • support and training of new group members • publication of a patent about a new method and detector prototype to measure the beam quality during treatment

- Radiotherapy - Medical devices - Simulations (Monte Carlo code FLUKA) - Dosimetry - Particle accelerators - X-Ray sources

nanotechnology - carbon nanotubes - cancer research - Raman spectroscopy - infrared spectroscopy - AFM

general physics - space probes dynamics